Running Contract for Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial.
CH-GRC-STORES/SOUTH EASTERN RLY · Pharmaceuticals · open
Key facts
- Published: 02 Sep 2026
- Closing date: 02 Sep 2026
- Status: open
Description
Tender for a running contract to supply Olopatadine HCI eye drops in 5ml phials, with a validity of 90 days, to various railway medical stores and depots in South Eastern Railway, India.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: Railway Board approved product list, Authorization letter from OEM (if applicable), Manufacturing unit details
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (5)
- Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial — Qty: 360 Numbers
- Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial — Qty: 96 Numbers
- Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial — Qty: 120 Numbers
- Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial — Qty: 165 Numbers
- Olopatadine HCI eye drop 0.1-0.2%, 5ml Phial — Qty: 1200 Numbers
3 tender document(s) available — sign up to download.